FIisiopharma capacity expansion project

Fisiopharma is thrilled to announce an ambitious project: the construction of a new state-of-the-art production building in Palomonte (SA), close to the current facility.This step marks a fundamental milestone in the company’s growth and innovation strategy, strengthening Fisiopharma’sposition in the injectable CDMO sector.

The new plant will be dedicated to manufacturing of sterile liquids in vials and pre-filled syringes and has been designedaccording to the highest international standards of quality, safety and environmental sustainability.Construction work began in December 2025 and the new production building is expected to be completedby early 2027.
The new area will offer new capacity of approximately: 40M vials/year and 40M pre-filled syringes/year.
Total Investment of 30MEuro.